Yahoo Web Search

Search results

    • Q1 2024 Supernus Pharmaceuticals Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 day ago

      Sdn for cohort three is our new stimulants life product candidate for ADHD and other CNS disorders. Finally, we remain active in corporate development. Looking...over to Tim ...